Resources

With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.

The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.

Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.

As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.

With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.

Qsight’s HME/DME Purchasing Data provides clients with real-time intelligence into market share and purchasing insights in the non-acute medical device sector. We looked at our capture of insulin pumps from the top players to assess market share and market growth in the durable medical equipment channel.

Guidepoint Qsight’s healthcare facilities purchasing dataset captures trends in multiple segments within the MedTech space. We break down insights on these segments and the top manufacturers in the space.

As MedSpas become an important growth driver for the medical aesthetics industry in the U.S., Qsight’s aesthetics point-of-sale data…

With Abbott announcing the availability of its Amplatzer Steerable Delivery Sheath, Guidepoint Qsight took a closer look at the left atrial appendage closure market…

Qsight’s medical device purchasing dataset captures trends in several markets, including the orthopedics market. We took a closer look at…

With the Omicron COVID-19 variant sweeping across the nation, Guidepoint Qsight has gathered insights from physicians on staffing shortages and…

After the launch of Penumbra’s new product, the RED 72 catheter, we took a look at its impact and other…

With Shockwave surpassing Wall Street’s expectations with their third-quarter earnings, Guidepoint Qsight took a closer look at how their new…

Guidepoint Qsight’s proprietary Aesthetics data examines patient spending in the United States, providing insight into brand retention in the Neurotoxin…

Guidepoint Qsight’s unique mix of quantitative healthcare facility purchasing data and qualitative commentary from our Tracker panel uncovers market share,…

Guidepoint Qsight captured insights into the overall U.S. Orthopedics Knee market, identifying tremendous double-digit growth in Q2 2021, up 13.5%…

Guidepoint Qsight’s medical device market-level dataset has captured trends in multiple MedTech market segments. Following the sharp drop at the…

Guidepoint Qsight’s data captured a surge in spending on non-surgical medical aesthetics treatments in March and April 2021. Neurotoxins, dermal…

Guidepoint Qsight is excited to announce the launch of a new Medical Aesthetics market intelligence offering where you can track…

Guidepoint Qsight’s healthcare facilities purchasing dataset provides insight into market share shifts in the neurology space from 2019 to 2020….

Guidepoint Qsight’s healthcare facilities purchasing dataset provides insight into market share shifts in the cardiology space from 2019 to 2020….

With COVID-19 continuing to create uncertainty, Guidepoint Qsight has gathered insights from U.S. physicians across healthcare markets on their expected…

Since the onset of COVID-19, Guidepoint Qsight’s healthcare facilities purchasing dataset has been capturing the effects of the pandemic on…

Guidepoint Qsight has been tracking the U.S. Peripheral Thrombectomy market, capturing a growth rate of +56.6% from 3Q19 to 3Q20….

Following temporary bans on elective procedures earlier this year due to the COVID-19 pandemic, Guidepoint Qsight was able to capture…

Guidepoint Qsight has been monitoring the number of U.S. COVID-19 cases per capita reported by state in 2Q20 and the relationship to changes in healthcare facility medical device purchasing.